More CTT Pharmaceutical Holdings, Inc. news
CTT Pharmaceutical Holdings, Inc.OTC: CTTH

CTT Pharma's Europe Patent Approved

Dec 5, 2022 · Issued by CTT Pharmaceutical Holdings, Inc.

On 6ix: 6ix.com/news/ctt-pharmas-europe-patent-approved

The original release is unavailable here.

CTT Pharmaceutical Holdings, Inc. on 6ix

Earlier from CTT Pharmaceutical

  • CTT Pharma Settles Lawsuit With AuroraDec 2, 2022
  • CTT Pharma Will Utilize Patented Technology for Additional Oral ProductsDec 1, 2022
  • CTT Enters into Business Development Partnership with 3 Rivers BiotechSep 8, 2020
  • CTT Pursues Expansion Into New Industry Verticals and the United States with Business Development AppointmentsSep 1, 2020
  • CTT Pharma Files Statement of Claim against Aurora Cannabis and Appoints Dr. Shane Morris to Advisory BoardAug 27, 2020

Later from CTT Pharmaceutical

  • CTT Pharma Signs Agreement for New Oral Product DevelopmentDec 6, 2022
  • CTT Parma Updates On Worldwide Patent PortfolioDec 19, 2022
  • CTT Pharma Corporate UpdatesJan 30, 2023
  • CTT Pharma Appoints David Paton, former Head Of Innovation at BAT, as Senior AdvisorMar 28, 2023
  • CTT Pharma News ReleaseOct 30, 2023
All CTT Pharmaceutical news releases↗

Follow CTT Pharmaceutical into a list and get an email when it puts out news.

Follow CTT Pharmaceutical
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer